Abstract
PMS17 - Cost Per-Responder Analysis of Secukinumab Compared To Other Biologics For The Treatment of Psoriatic Arthritis In Saudi Arabia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have